| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 22.221 | 44.900 | 46.371 | 48.414 | 37.496 | 37.928 | 42.164 | 59.924 | 57.475 |
| Total Income - EUR | - | 22.221 | 44.900 | 46.413 | 48.511 | 37.496 | 37.928 | 42.307 | 65.930 | 69.177 |
| Total Expenses - EUR | - | 6.964 | 4.407 | 19.386 | 26.744 | 13.351 | 18.812 | 25.313 | 58.167 | 95.042 |
| Gross Profit/Loss - EUR | - | 15.257 | 40.493 | 27.027 | 21.766 | 24.145 | 19.115 | 16.994 | 7.763 | -25.866 |
| Net Profit/Loss - EUR | - | 14.590 | 37.544 | 25.871 | 20.311 | 23.065 | 17.977 | 15.990 | 7.175 | -27.590 |
| Employees | - | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Filoderm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 32.630 | 30.010 | 27.476 | 25.008 | 22.634 | 20.275 | 20.295 | 225.528 | 207.494 |
| Current Assets | - | 11.757 | 25.749 | 19.318 | 15.776 | 10.097 | 34.450 | 25.209 | 48.659 | 13.311 |
| Inventories | - | 0 | 0 | 2.626 | 5.154 | 3.945 | 4.297 | 2.746 | 9.410 | 7.931 |
| Receivables | - | 6.670 | 7.689 | 0 | 2.915 | 1.959 | 0 | 16.847 | 38.351 | 0 |
| Cash | - | 5.087 | 18.060 | 9.171 | 7.707 | 4.193 | 30.153 | 5.616 | 898 | 5.380 |
| Shareholders Funds | - | 14.635 | 37.597 | 42.431 | 26.227 | 28.869 | 44.185 | 33.312 | 12.851 | -14.811 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 29.752 | 18.162 | 4.363 | 14.557 | 3.861 | 10.540 | 10.371 | 65.647 | 52.736 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.820 | 195.689 | 182.894 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Filoderm Srl